About: http://webisa.webdatacommons.org/120769682

Property	Value
http://www.w3.org/1999/02/22-rdf-syntax-ns#type	http://www.w3.org/ns/prov#Entity
http://www.w3.org/ns/prov#value	In September 2012 the FDA informed the drug company Sanofi-Aventis that it had approved some label changes for Multaq, including one about certain types of lung disease and pulmonary toxicity as being serious side effects of Multaq use.
http://www.w3.org/ns/prov#wasQuotedFrom	drug-injury.com